Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Different fields of expertise must work together to better understand hair growth and create effective hair loss treatments.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Hair shaft disorders, often due to genetics or environment, lack specific treatments but can be managed with gentle hair care and may improve with age or topical treatments.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Hair loss affects self-esteem and quality of life; treatments can help.

Hair loss linked to higher heart disease risk in both men and women.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Proper scalp care can improve hair health and delay ageing signs.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

The skin's microbiome helps hair regrow by boosting certain cell signals and metabolism.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

Mechanical stimulation and new therapies show promise for hair regrowth.

Eating foods rich in vitamin D and iron helps prevent hair loss, while alcohol and sugary drinks can cause it.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Long scalp hair evolved for cooling and social signaling.

Autophagy helps activate hair stem cells and hair growth by changing their energy use to glycolysis.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

Scalp micropigmentation, a cosmetic tattoo technique, is a promising non-surgical treatment for hair and scalp deformities, despite potential complications.

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.